Last reviewed · How we verify
A Proof of Concept Study to Evaluate the Additive Effects of HFA-BDP (Qvar) to Fluticasone/Salmeterol (Seretide) on Surrogate Markers of Small and Large Airway Inflammation in Refractory Asthma (PAW01)
The purpose of this study is to establish whether addition of extra-fine particle steroid inhalers achieve additional suppression of small airways inflammation when added to 'standard' Fluticasone/Salmeterol combination therapy in refractory asthma.
Details
| Lead sponsor | University of Dundee |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 15 |
| Start date | 2009-01 |
| Completion | 2010-07 |
Conditions
- Asthma
Interventions
- HFA-BDP
- Fluticasone
- Seretide
Primary outcomes
- Alveolar nitric oxide — 16 weeks
Countries
United Kingdom